What we do

Our focus  is on improving early diagnosis of pancreatic cancer and improving the quality of life for those affected by pancreatic cancer.

Currently there are over 9,000 people newly diagnosed a year with pancreatic cancer.  We’re on a mission to stamp out late detection which is the reason that the survival rate has remained at between 2% – 4% for nearly 50 years.

Find out more about what we do: